Advertisement
Document › Details
[iito] Business Intelligence. (11/8/20). "The [LSUS] Newsletter Is Out! Hand-picked & Manually Edited Transatlantic Life Science Business News from Europe and North America". Bremen.
You can read the latest version of the [LSUS] Newsletter online at
https://www.life-sciences-europe.com/newsletter/lsus-newsletter-021011-asex.html
This issue features:
Novo Nordisk – Emisphere Technologies – PerkinElmer – Horizon Discovery – Sanofi – Kiadis Pharma – Fountain Healthcare Partners Fund III – Novartis – Vedere Bio – Definitive Healthcare – Monocl – Galecto – Nasdaq Global Market – Exact Sciences – Thrive Earlier – Base Genomics – Eagle Genomics – Prokarium – Ogilvy Health – Kate Cronin – Carl Wittwer – Scope Fluidics – Atbtherapeutics – Selexis – Promethean Particles – James Stephenson – TVM Capital Life Sciences Innovation II Fund – Eternygen – Evotec – Bayer – AskBio – CRISPR Therapeutics – MLM Medical Labs – MD Biosciences – Scorpion Therapeutics – Abcam – Atea – Roche – SparingVision – Stéphane Boissel – KBI Biopharma – Kynexis Medicine – NBE-Therapeutics – Vifor Pharma – Cara Tx – Immunic – European Investment Bank (EIB) – Cevec – Rznomics – Medigene – Cytovant – Rentschler Biopharma – ATUM – Regulatory and Quality Solutions (R&Q) – Maetrics – Exelixis
Record changed: 2023-06-05 |
Advertisement
More documents for Fountain Healthcare Partners (IE)
- [1] Dualyx N.V.. (5/15/23). "Press Release: Dualyx Raises €40 Million to Progress Treg Therapies for Autoimmune Diseases into the Clinic". Ghent....
- [2] Fountain Healthcare Partners. (11/2/20). "Press Release: Fountain Healthcare Partners Announces Final Close of €125 Million for Fund III"....
- [3] Priothera Ltd.. (10/12/20). "Press Release: Priothera Closes €30 Million Series A Financing to Develop Highly Promising Therapies for Acute Myeloid Leukemia (AML)". Dublin....
- [4] Fountain Healthcare Partners. (5/23/19). "Press Release: Fountain Healthcare Partners Raises €118M for Third Fund. Fund Raise Exceeds Target of €100m". Dublin & New York, NY....
- [5] Nerre Therapeutics Ltd.. (1/5/17). "Press Release: Nerre Therapeutics Raises £23 Million in Oversubscribed Series B Financing Round". Paris & Boston, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top